Post-traumatic Cutaneous Mucormycosis in Diabetes Mellitus

Abstract

Mucormycosis is infrequently encountered in the pediatric population in any of its forms (nasopharyngeal, disseminated, pulmonary, or cutaneous) and generally is associated with the immunocompromised host.

We present an adolescent with poorly controlled diabetes mellitus who developed a progressive skin lesion 3 weeks after a motor vehicle accident. Rhizopus species was isolated from the lesion, and the biopsy revealed a fungal vasculopathy. Control of her diabetes, aggressive surgical intervention and a 10-day course of antifungal therapy (amphotericin B) resulted in a favorable outcome.

This article illustrates the importance of considering cutaneous fungal infections, especially those in the class zygomycetes, in the diabetic patient with unusual, severe or persistent skin lesions. Early recognition is essential in order to avoid morbidity and mortality from this unusual opportunistic infection.

Get full access to this article

View all access options for this article.

References

Lehrer RI , Howard DH , Sypherd PS , Edwards JE , Segal SP , Winston DJ Mucormycosis. UCLA Conference. Ann Intern Med 1980;93:93-108.

Kline MW Mucormycosis in children: Review of the literature and report of cases. Pediatr Infect Dis J 1985;4:672-6.

Ryan ME , Ochs J. Primary cutaneous mucormycosis: Superficial and gangrenous infections. Pediatr Infect Dis J 1982;2:110-4.

White CB , Barcia PJ , Bass JW Neonatal Zygomycotic necrotizing cellulitis. Pediatrics 1986;78:100-2.

Johnson GM , Baldwin JJ Pulmonary mucormycosis and juvenile diabetes. Am J Dis Child 1981;135:567-8.

Gartenburg G. , Bottone EJ , Keusch GT , Weitzman I. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue. N Engl J Med 1978;299:1115-8.

Centers for Disease Control. Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings-Minnesota. MMWR 1978; 27:33-44.

Vainrub B. , Macareno A. , Mandel S. , Musher DM Wound Zygomycosis (mucormycosis) in otherwise healthy adults. Am J Med 1988;84:546-8.

Medoff G. , Brajtburg J. , Kobayashi GS Antifungal agents useful in therapy of systemic fungal infections. Ann Rev Pharmacol Toxicol 1983;23:303-30.

10.

Medoff G. , Kobayashi GS Strategies in the treatment of systemic fungal infections. New Engl J Med 1980;302:145-55.

11.

Medoff G. Controversial areas in antifungal chemotherapy: Short course and combination therapy with amphotericin B. Rev Infect Dis 1987;9:403-7.